Back to Dermatology
Dermatologyv2014Evidence-Based

Urticaria Activity Score (UAS)

Stratifies severity of urticaria through diary-based assessment of wheals and itch intensity. The UAS7 score (weekly score) is calculated by summing daily scores over 7 consecutive days, providing a standardized measure for chronic spontaneous urticaria activity monitoring and treatment response assessment.

Clinical Input Parameters

points
points
points
points
points
points
points
points
points
points
points
points
points
points
Clinical Assessment
Awaiting Parameters
uas7 score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Urticaria Activity Score (UAS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within dermatology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

UAS7 = Σ(daily wheals score + daily itch score) over 7 consecutive days

Clinical Pearls & Practice Notes

  • Wheals scoring: 0=None, 1=Mild (<20 wheals/24h), 2=Moderate (20-50 wheals/24h), 3=Intense (>50 wheals/24h or large confluent areas)
  • Itch scoring: 0=None, 1=Mild (present but not annoying), 2=Moderate (troublesome but doesn't interfere with daily activity), 3=Intense (severe, interferes with daily activity or sleep)
  • Daily UAS = wheals score + itch score (range 0-6 per day)
  • UAS7 = sum of daily UAS scores over 7 consecutive days (range 0-42)
  • A cutoff of UAS7 ≥11 has shown sensitivity of 74% and specificity of 86% for identifying active disease
  • UAS7 <7 generally indicates adequate disease control
  • UAS7 >28 indicates severe disease activity requiring intensive management
  • The UAS is recommended by international guidelines for monitoring chronic spontaneous urticaria
  • Daily assessments should be completed at the same time each day, preferably in the evening
  • The UAS7 is the primary endpoint in many clinical trials for chronic urticaria treatments
  • Consider using UAS for treatment response assessment and therapy optimization decisions

Evidence & Literature Citations

  1. Młynek A, Zalewska-Janowska A, Martus P, et al. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63(6):777-780.
  2. Hawro T, Ohanyan T, Schoepke N, et al. The Urticaria Activity Score--Validity, Reliability, and Responsiveness. J Allergy Clin Immunol Pract. 2018;6(4):1185-1190.e1.
  3. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA²LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2014 revision. Allergy. 2014;69(7):868-887.

Score Interpretation Ranges

Urticaria-free0 – 0 pts

No urticaria activity

Well-controlled1 – 6 pts

Very mild urticaria activity

Mild7 – 15 pts

Mild urticaria activity

Moderate16 – 27 pts

Moderate urticaria activity

Severe28 – 42 pts

Severe urticaria activity

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.